1
|
Nirwan N, Nikita, Sultana Y, Vohora D. Liposomes as multifaceted delivery system in the treatment of osteoporosis. Expert Opin Drug Deliv 2021; 18:761-775. [PMID: 33406945 DOI: 10.1080/17425247.2021.1867534] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Introduction: Treatment of osteoporosis with the available drug formulations is still challenging due to multiple associated limitations such as chronic treatment, off-target side effects, poor bone targeting, and low bioavailability. Adopting advanced bone-targeted drug delivery strategies like liposomes is one of the safe and effective approaches for osteoporosis treatment.Areas covered: This review summarizes the applications of liposomes in gene delivery, bone regeneration, bone-targeted delivery, and as a carrier for drug encapsulation in the treatment of osteoporosis. Details of all the supportive studies are discussed here and the bone-specific roles of the strategies like new generation liposomes in osteoporosis are elaborated. The future scope of performing in-depth research on the bone-targeted liposomes is discussed.Expert opinion: Liposomes-based bone-targeted delivery of therapeutics seems to be a promising approach for the effective treatment of osteoporosis. But till date, the tremendous in vitro and in vivo research on liposomes has failed to attain significant progress in their clinical translation. From bench to bedside success of the research an interdisciplinary collaboration between the preclinical and clinical experts engaged at different stages of liposomes development is required.
Collapse
Affiliation(s)
- Nikita Nirwan
- Neurobehavioral Pharmacology Laboratory, Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
| | - Nikita
- Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
| | - Yasmin Sultana
- Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
| | - Divya Vohora
- Neurobehavioral Pharmacology Laboratory, Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
| |
Collapse
|
2
|
Matos C, Lobão P. Non-Steroidal Anti-Inflammatory Drugs Loaded Liposomes for Topical Treatment of Inflammatory and Degenerative Conditions. Curr Med Chem 2020; 27:3809-3829. [DOI: 10.2174/0929867326666190227233321] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2018] [Revised: 12/27/2018] [Accepted: 02/15/2019] [Indexed: 12/18/2022]
Abstract
Topical administration of drugs presents some advantages over other routes; the drug can be
administered in the anatomical region to be treated, limiting the systemic distribution and side effects.
However, the structure of the skin makes it a highly effective barrier to drug permeation. Amongst the
strategies to overcome this obstacle, liposomes are interesting vehicles for delivering the drugs into the
skin, the synovial cavity or other regions affected by inflammatory or degenerative conditions.
Liposomes are lipid carriers of nanometric size formed by phospholipid bilayers. They have the advantages
of preparation feasibility and biological compatibility associated with the possibility of carrying
either lipophylic and/or hydrophylic compounds, and have been extensively used in various drug delivery
systems, for drug targeting, controlled release and permeation enhancement of drugs. Conventional
liposomes are not very stable and not suitable for dermal administration after topical application, since
they accumulate on the skin surface due to the rigidity of the lipid layers and suffer dehydration, culminating
in their fragmentation. Other formulations have emerged in the meantime, such as transfersomes,
niosomes or ethosomes. The present work consists of a review on the published scientific papers regarding
the development of liposomal formulations containing non-steroidal anti-inflammatory drugs for the
purpose of relieving the symptomatology of inflammatory and degenerative ailments. The exposition
summarizes data relating to liposome type, composition, preparation method, liposome characterization,
topical vehicle used, in vitro permeation studies performed, in vivo anti-inflammatory assays carried out
and results obtained in the different studies published in the last five years.
Collapse
Affiliation(s)
- Carla Matos
- FP-ENAS-UFP Energy, Environment and Health Research Unit/CEBIMED-Centro de Estudos em Biomedicina, Fernando Pessoa University, Porto, Portugal
| | - Paulo Lobão
- Research Centre for Pharmaceutical Sciences, Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
| |
Collapse
|
3
|
Percutaneous delivery of levetiracetam as an alternative to topical nonsteroidal anti-inflammatory drugs: formulation development, in vitro and in vivo characterization. Drug Deliv Transl Res 2020; 11:227-241. [PMID: 32451940 DOI: 10.1007/s13346-020-00787-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
The study focused on formulation of carmellose sodium hydrogels and nonionic microemulsions with 5% and 10% of levetiracetam and investigation of drug concentration influence on their physicochemical characteristics and in-use stability as well as influence of drug concentration and carrier type on in vitro drug release and in vivo antihyperalgesic/antiedematous activity in a rat model of localized (intraplantar) carrageenan-induced inflammation. Hydrogels were pseudoplastic semisolids with thixotropy and pH 7.37-7.58. Microemulsions were low viscous Newtonian nanodispersions of oil droplets (13.11-15.11 nm) in water, with pH 4.01-4.64. Physical stability of the investigated systems was preserved over the 3-month storage under ambient conditions. Levetiracetam release followed zero order and Korsmeyer-Peppas models (R2 ≥ 0.99) reflecting the combined effects of drug concentration and carrier viscosity. All levetiracetam-loaded formulations produced significant reduction of hyperalgesia and paw swelling induced by carrageenan (p < 0.001). Their efficacy in exerting antihyperalgesic activity was significantly higher than that observed with the reference 5% ibuprofen hydrogel preparation (up to 6 h) (p < 0.001), while antiedematous activity was comparable with the reference product. No erythema and visible blood vessels were observed in a rat ear test. The study demonstrated percutaneous delivery of levetiracetam as useful and safe therapeutic option for localized inflammatory pain with potential to overcome the insufficient efficacy of topically applied nonsteroidal anti-inflammatory drugs in the form of a hydrogel. Graphical abstract.
Collapse
|
4
|
Calienni MN, Temprana CF, Prieto MJ, Paolino D, Fresta M, Tekinay AB, Alonso SDV, Montanari J. Nano-formulation for topical treatment of precancerous lesions: skin penetration, in vitro, and in vivo toxicological evaluation. Drug Deliv Transl Res 2018; 8:496-514. [PMID: 29288359 DOI: 10.1007/s13346-017-0469-1] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
With the aim of improving the topical delivery of the antineoplastic drug 5-fluorouracil (5FU), it was loaded into ultradeformable liposomes composed of soy phosphatidylcholine and sodium cholate (UDL-5FU). The liposome populations had a mean size of 70 nm without significant changes in 56 days, and the ultradeformable formulations were up to 324-fold more elastic than conventional liposomes. The interaction between 5FU and the liposomal membrane was studied by three methods, and also release profile was obtained. UDL-5FU did penetrate the stratum corneum of human skin. At in vitro experiments, the formulation was more toxic on a human melanoma-derived than on a human keratinocyte-derived cell line. Cells captured liposomes by metabolically active processes. In vivo toxicity experiments were carried out in zebrafish (Danio rerio) larvae by studying the swimming activity, morphological changes, and alterations in the heart rate after incubation. UDL-5FU was more toxic than free 5FU. Therefore, this nano-formulation could be useful for topical application in deep skin precancerous lesions with advantages over current treatments. This is the first work that assessed the induction of apoptosis, skin penetration in a Saarbrücken penetration model, and the toxicological effects in vivo of an ultradeformable 5FU-loaded formulation.
Collapse
Affiliation(s)
- Maria Natalia Calienni
- Laboratorio de Biomembranas, Departamento de Ciencia y Tecnología, GBEyB. IMBICE, CCT-LA PLATA, CONICET, Universidad Nacional de Quilmes, Bernal, B1876BXD, Buenos Aires, Argentina.,Department of Experimental and Clinical Medicine, University "Magna Græcia" of Catanzaro, Campus Universitario "S. Venuta", Viale S. Venuta, Germaneto, I-88100, Catanzaro, Italy
| | - Carlos Facundo Temprana
- Laboratorio de Inmunología y Virología (LIV), Departamento de Ciencia y Tecnología, CONICET, Universidad Nacional de Quilmes, B1876BXD, Bernal, Argentina
| | - Maria Jimena Prieto
- Laboratorio de Biomembranas, Departamento de Ciencia y Tecnología, GBEyB. IMBICE, CCT-LA PLATA, CONICET, Universidad Nacional de Quilmes, Bernal, B1876BXD, Buenos Aires, Argentina
| | - Donatella Paolino
- Department of Experimental and Clinical Medicine, University "Magna Græcia" of Catanzaro, Campus Universitario "S. Venuta", Viale S. Venuta, Germaneto, I-88100, Catanzaro, Italy
| | - Massimo Fresta
- Department of Health Sciences, University "Magna Græcia" of Catanzaro, Campus Universitario "S. Venuta", Viale S. Venuta, Germaneto, I-88100, Catanzaro, Italy
| | - Ayse Begum Tekinay
- Institute of Materials Science and Nanotechnology, National Nanotechnology Research Center (UNAM), Bilkent University, 06800, Ankara, Turkey
| | - Silvia Del Valle Alonso
- Laboratorio de Biomembranas, Departamento de Ciencia y Tecnología, GBEyB. IMBICE, CCT-LA PLATA, CONICET, Universidad Nacional de Quilmes, Bernal, B1876BXD, Buenos Aires, Argentina
| | - Jorge Montanari
- Laboratorio de Biomembranas, Departamento de Ciencia y Tecnología, GBEyB. IMBICE, CCT-LA PLATA, CONICET, Universidad Nacional de Quilmes, Bernal, B1876BXD, Buenos Aires, Argentina. .,Institute of Materials Science and Nanotechnology, National Nanotechnology Research Center (UNAM), Bilkent University, 06800, Ankara, Turkey.
| |
Collapse
|